Literature DB >> 18751195

Topic in Review: Vaccines in the 21st century.

M A Liu1.   

Abstract

Year:  1999        PMID： 18751195      PMCID： PMC1308748     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  18 in total

1.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Authors:  H S Mason; J M Ball; J J Shi; X Jiang; M K Estes; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

2.  Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

Authors:  D R Sizemore; A A Branstrom; J C Sadoff
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

3.  Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.

Authors:  G Ferrari; W Humphrey; M J McElrath; J L Excler; A M Duliege; M L Clements; L C Corey; D P Bolognesi; K J Weinhold
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 4.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; J W Shiver; M A Liu
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

Authors:  K L Kotloff; F Noriega; G A Losonsky; M B Sztein; S S Wasserman; J P Nataro; M M Levine
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.

Authors:  C O Tacket; S M Kelly; F Schödel; G Losonsky; J P Nataro; R Edelman; M M Levine; R Curtiss
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 7.  Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.

Authors:  M M Levine; J Galen; E Barry; F Noriega; S Chatfield; M Sztein; G Dougan; C Tacket
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

Review 8.  Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses.

Authors:  D M Hone; S Wu; R J Powell; D W Pascual; J Van Cott; J McGhee; T R Fouts; R G Tuskan; G K Lewis
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

9.  Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

Authors:  K L Nichol; P M Mendelman; K P Mallon; L A Jackson; G J Gorse; R B Belshe; W P Glezen; J Wittes
Journal:  JAMA       Date:  1999-07-14       Impact factor: 56.272

10.  Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.

Authors:  G Douce; C Turcotte; I Cropley; M Roberts; M Pizza; M Domenghini; R Rappuoli; G Dougan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.